Instem PLC Company Profile (LON:INS)

About Instem PLC (LON:INS)

Instem PLC logoInstem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market. The Provantis solution incorporates a suite of modules required for managing and recording EDSA studies, from receipt of the compound through to the automated assembly of statistical analyses and final reports. Its software allows scientific staff to collect, analyze and share data across the organization and externally. It also offers ALPHADAS, an early phase clinical software solution. The Company offers Centrus suite, which provides pre-built applications, as well as the ability to utilize a range of business intelligence and analysis tools.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: IT Services & Consulting - NEC
  • Sub-Industry: N/A
  • Symbol: LON:INS
  • CUSIP: N/A
  • Web: www.instem.com/
Capitalization:
  • Market Cap: £30.99 million
  • Outstanding Shares: 15,771,000
Average Prices:
  • 50 Day Moving Avg: GBX 196.85
  • 200 Day Moving Avg: GBX 202.67
  • 52 Week Range: GBX 171 - GBX 328.55
P/E:
  • Trailing P/E Ratio: 28.90
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £18.32 million
  • Price / Sales: 1.69
  • Book Value: GBX 0.81 per share
  • Price / Book: 2.43
Profitability:
  • EBIDTA: $734,000.00
  • Net Margins: 10.76%
  • Return on Equity: 16.38%
  • Return on Assets: 6.81%
Misc:
  • Average Volume: 7,569 shs.
 

Frequently Asked Questions for Instem PLC (LON:INS)

What is Instem PLC's stock symbol?

Instem PLC trades on the London Stock Exchange (LON) under the ticker symbol "INS."

Who are some of Instem PLC's key competitors?

Who are Instem PLC's key executives?

Instem PLC's management team includes the folowing people:

  • Philip John Reason, Chief Executive Officer, Executive Director
  • Nigel John Goldsmith, Chief Financial Officer, Company Secretary, Executive Director
  • MaryBeth Thompson, Chief Operating Officer
  • David Gare, Non-Executive Chairman of the Board
  • David M. Sherwin, Non-Executive Director
  • Michael Frederick McGoun, Non-Executive Independent Director

How do I buy Instem PLC stock?

Shares of Instem PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Instem PLC's stock price today?

One share of Instem PLC stock can currently be purchased for approximately GBX 196.50.


MarketBeat Community Rating for Instem PLC (LON INS)
Community Ranking:  0.5 out of 5 ()
Outperform Votes:  9 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about Instem PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Instem PLC (LON:INS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Instem PLC (LON:INS)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2016N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 7/21/2015 forward)

Earnings

Earnings History for Instem PLC (LON:INS)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Instem PLC (LON:INS)
Current Year EPS Consensus Estimate: $2.10 EPS

Dividends

Dividend History for Instem PLC (LON:INS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Instem PLC (LON:INS)
Insider Trades by Quarter for Instem PLC (LON:INS)
Insider Trades by Quarter for Instem PLC (LON:INS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/23/2016Sherwin,DavidInsiderSell200,000GBX 200£400,000
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Instem PLC (LON:INS)
Latest Headlines for Instem PLC (LON:INS)
Source:
DateHeadline
morningstar.co.uk logoInstem's 2016 Results Dragged Down By "Disappointing" Clinical Unit
www.morningstar.co.uk - March 28 at 11:11 AM
finance.yahoo.com logoGlobal Bioinformatics - Biotechnology - Yahoo Finance
finance.yahoo.com - February 22 at 11:11 PM
bizjournals.com logoBioinformatics - Global Strategic Business Report 2017 - Research and Markets
www.bizjournals.com - February 22 at 12:37 PM
uk.finance.yahoo.com logoBioKinetic Europe Goes Live with ALPHADAS Early Phase Software for Full End-to-End Capabilities
uk.finance.yahoo.com - January 19 at 7:41 PM
morningstar.co.uk logoInstem Appoints MaryBeth Thompson As Chief Operating Officer
www.morningstar.co.uk - January 9 at 11:41 PM
morningstar.co.uk logoInstem Says Acquisitions Bolster Pipeline As Interim Profit Declines
www.morningstar.co.uk - September 20 at 10:46 AM
morningstar.co.uk logoInstem Buys Software Company Notocord For EUR4.2 Million
www.morningstar.co.uk - September 5 at 5:07 PM

Social

Social activity is not available for this stock.

Chart

Instem PLC (INS) Chart for Friday, July, 21, 2017

This page was last updated on 7/21/2017 by MarketBeat.com Staff